PropertyValue
?:abstract
  • Coronavirus disease 2019 (COVID-19) pandemic gripped the globe SARS-CoV-2 is highly infectious and is susceptible to all populations Immunosuppressed patients have greater risk for opportunistic infections However, the understanding regarding the biological characteristics of SARSCoV-2 in immunosuppressed patients remains unclear Herein, we present a case of prolonged shedding of SARS-CoV-2 in a liver transplant patient with COVID-19 A 61-year-old male post liver transplant was confirmed COVID-19 infection on day 10 of illness onset The patient has received immunosuppressive treatment for over 11 years and has a history of hypertension for 10 years With antiviral treatment and temporary discontinuation of tacrolimus immunosuppression, he had complete clinical symptoms relieve on day 24 However, recurrently positive tests of SARS-CoV-2 RNA were presented on day 35 and on day 39 after two consecutive negative tests IgG antibody test for SARS-CoV-2 was positive with IgM negative on day 41 The final shedding duration lasted 52 days Prolonged shedding of SARS-CoV-2 should be a matter of concern and might attribute to long-term immunosuppression Therefore, dynamic surveillance and prolonged quarantine are required for immunocompromised individuals Further data should be collected to investigate if there is a universal prolonged shedding window of SARS-CoV-2 in immunosuppressed patients
is ?:annotates of
?:creator
?:journal
  • Ann_Palliat_Med
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Prolonged shedding of SARS-CoV-2 in an elderly liver transplant patient infected by COVID-19: a case report
?:type
?:who_covidence_id
  • #923003
?:year
  • 2020

Metadata

Anon_0  
expand all